Kolexia
Murati Anne Pharmacien
Murati Anne
Pharmacien
Centre Paoli-Calmettes
Marseille, France
57 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Syndromes myélodysplasiques Syndromes myéloprolifératifs Leucémie aigüe myéloïde Leucémie myéloïde Myélofibrose primitive Leucémie myélomonocytaire chronique Thrombocytose Thrombocytémie essentielle

Collaborateurs

Voir plus
Gelsi-Boyer Veronique
Gelsi-Boyer Veronique
Centre Paoli-Calmettes, Marseille, France
Mozziconacci Marie-Joelle
Mozziconacci Marie-Joelle
Centre Paoli-Calmettes, Marseille, France
Vey Norbert
Vey Norbert
Centre Paoli-Calmettes, Marseille, France
Rey Jerome
Rey Jerome
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
Janssen
2 collaboration(s)
Dernière en 2021
Abbvie
1 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
European journal of haematology   29 novembre 2023
Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation
65th ASH Annual Meeting Abstracts   02 novembre 2023
Parental thoughts after the Codroipo case: the other side of the story.
Annali di igiene : medicina preventiva e di comunita   11 octobre 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
Blood advances   31 mai 2021
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.
Blood advances   14 mai 2021
Gains of EPOR and ERG genes in adult erythroleukaemia.
British journal of haematology   29 mars 2020
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.
British journal of haematology   11 novembre 2019
Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.
Haematologica   10 octobre 2019
Targeted molecular characterization shows differences between primary and secondary myelofibrosis.
Genes, chromosomes & cancer   02 septembre 2019